Selected research
Market Structure
Global Nanomedicine Manufacturing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Nanomedicine Manufacturing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Nanomedicine Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Nanomedicine Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nanomedicine Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Nanomedicine Manufacturing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nanomedicine Manufacturing Services include nanoComposix, Ardena Nanomedicines, Cytiva, Inside Therapeutics, Fortis Life Sciences, AstraZeneca, Ascendia Pharmaceuticals, Axolabs and AVANSA Technology & Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Nanomedicine Manufacturing Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Nanomedicine Manufacturing Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Nanomedicine Manufacturing Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nanomedicine Manufacturing Services market size, projected growth trends, production technologies, key applications, and end-use industries.
Nanomedicine Manufacturing Services Segment by Company
nanoComposix
Ardena Nanomedicines
Cytiva
Inside Therapeutics
Fortis Life Sciences
AstraZeneca
Ascendia Pharmaceuticals
Axolabs
AVANSA Technology & Services
MyBiotech
Nanochemazone
TechNanoIndia
Encapsula NanoSciences
STA Pharmaceutical Co. Ltd.
Nanomedicine Manufacturing Services Segment by Type
Nanocarrier Construction
Drug Production
Quality Testing
Process Development
Nanomedicine Manufacturing Services Segment by Application
Cancer
Cardiovascular Disease
Nervous System Disease
Infectious Disease
Others
Nanomedicine Manufacturing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanomedicine Manufacturing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanomedicine Manufacturing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanomedicine Manufacturing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nanomedicine Manufacturing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nanomedicine Manufacturing Services industry.
Chapter 3: Detailed analysis of Nanomedicine Manufacturing Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanomedicine Manufacturing Servicesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nanocarrier Construction
- Drug Production
- Quality Testing
- Process Development
Applications
- Cancer
- Cardiovascular Disease
- Nervous System Disease
- Infectious Disease
- Others
Companies covered
- nanoComposix
- Ardena Nanomedicines
- Cytiva
- Inside Therapeutics
- Fortis Life Sciences
- AstraZeneca
- Ascendia Pharmaceuticals
- Axolabs
- AVANSA Technology & Services
- MyBiotech
- Nanochemazone
- TechNanoIndia
- Encapsula NanoSciences
- STA Pharmaceutical Co. Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Nanomedicine Manufacturing Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Nanocarrier Construction
- 1.2.3 Drug Production
- 1.2.4 Quality Testing
- 1.2.5 Process Development
- 1.3 Market Analysis by Application
- 1.3.1 Global Nanomedicine Manufacturing Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Cancer
- 1.3.3 Cardiovascular Disease
- 1.3.4 Nervous System Disease
- 1.3.5 Infectious Disease
- 1.3.6 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Nanomedicine Manufacturing Services Growth Trends by Region
- 1.5.1 Global Nanomedicine Manufacturing Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Nanomedicine Manufacturing Services Market Size by Region (2021-2026)
- 1.5.3 Nanomedicine Manufacturing Services Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Nanomedicine Manufacturing Services Market Dynamics
- 2.1 Nanomedicine Manufacturing Services Industry Trends
- 2.2 Nanomedicine Manufacturing Services Industry Drivers
- 2.3 Nanomedicine Manufacturing Services Industry Opportunities and Challenges
- 2.4 Nanomedicine Manufacturing Services Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Nanomedicine Manufacturing Services Revenue by Company (2021-2026)
- 3.2 Global Nanomedicine Manufacturing Services Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Nanomedicine Manufacturing Services Key Company Head office and Area Served
- 3.4 Global Nanomedicine Manufacturing Services Company, Product Type & Application
- 3.5 Global Nanomedicine Manufacturing Services Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Nanomedicine Manufacturing Services Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Nanomedicine Manufacturing Services Players Market Share by Revenue in 2025
- 3.6.3 2025 Nanomedicine Manufacturing Services Tier 1, Tier 2, and Tier 3
4 Nanomedicine Manufacturing Services Market by Type
- 4.1 Global Nanomedicine Manufacturing Services Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Nanomedicine Manufacturing Services Market Size by Type (2021-2032)
- 4.3 Global Nanomedicine Manufacturing Services Market Size Share by Type (2021-2032)
5 Nanomedicine Manufacturing Services Market by Application
- 5.1 Global Nanomedicine Manufacturing Services Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Nanomedicine Manufacturing Services Market Size by Application (2021-2032)
- 5.3 Global Nanomedicine Manufacturing Services Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 nanoComposix
- 6.1.1 nanoComposix Company Information
- 6.1.2 nanoComposix Business Overview
- 6.1.3 nanoComposix Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 nanoComposix Nanomedicine Manufacturing Services Product Portfolio
- 6.1.5 nanoComposix Recent Developments
- 6.2 Ardena Nanomedicines
- 6.2.1 Ardena Nanomedicines Company Information
- 6.2.2 Ardena Nanomedicines Business Overview
- 6.2.3 Ardena Nanomedicines Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Ardena Nanomedicines Nanomedicine Manufacturing Services Product Portfolio
- 6.2.5 Ardena Nanomedicines Recent Developments
- 6.3 Cytiva
- 6.3.1 Cytiva Company Information
- 6.3.2 Cytiva Business Overview
- 6.3.3 Cytiva Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Cytiva Nanomedicine Manufacturing Services Product Portfolio
- 6.3.5 Cytiva Recent Developments
- 6.4 Inside Therapeutics
- 6.4.1 Inside Therapeutics Company Information
- 6.4.2 Inside Therapeutics Business Overview
- 6.4.3 Inside Therapeutics Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Inside Therapeutics Nanomedicine Manufacturing Services Product Portfolio
- 6.4.5 Inside Therapeutics Recent Developments
- 6.5 Fortis Life Sciences
- 6.5.1 Fortis Life Sciences Company Information
- 6.5.2 Fortis Life Sciences Business Overview
- 6.5.3 Fortis Life Sciences Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Fortis Life Sciences Nanomedicine Manufacturing Services Product Portfolio
- 6.5.5 Fortis Life Sciences Recent Developments
- 6.6 AstraZeneca
- 6.6.1 AstraZeneca Company Information
- 6.6.2 AstraZeneca Business Overview
- 6.6.3 AstraZeneca Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 AstraZeneca Nanomedicine Manufacturing Services Product Portfolio
- 6.6.5 AstraZeneca Recent Developments
- 6.7 Ascendia Pharmaceuticals
- 6.7.1 Ascendia Pharmaceuticals Company Information
- 6.7.2 Ascendia Pharmaceuticals Business Overview
- 6.7.3 Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Product Portfolio
- 6.7.5 Ascendia Pharmaceuticals Recent Developments
- 6.8 Axolabs
- 6.8.1 Axolabs Company Information
- 6.8.2 Axolabs Business Overview
- 6.8.3 Axolabs Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Axolabs Nanomedicine Manufacturing Services Product Portfolio
- 6.8.5 Axolabs Recent Developments
- 6.9 AVANSA Technology & Services
- 6.9.1 AVANSA Technology & Services Company Information
- 6.9.2 AVANSA Technology & Services Business Overview
- 6.9.3 AVANSA Technology & Services Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 AVANSA Technology & Services Nanomedicine Manufacturing Services Product Portfolio
- 6.9.5 AVANSA Technology & Services Recent Developments
- 6.10 MyBiotech
- 6.10.1 MyBiotech Company Information
- 6.10.2 MyBiotech Business Overview
- 6.10.3 MyBiotech Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 MyBiotech Nanomedicine Manufacturing Services Product Portfolio
- 6.10.5 MyBiotech Recent Developments
- 6.11 Nanochemazone
- 6.11.1 Nanochemazone Company Information
- 6.11.2 Nanochemazone Business Overview
- 6.11.3 Nanochemazone Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Nanochemazone Nanomedicine Manufacturing Services Product Portfolio
- 6.11.5 Nanochemazone Recent Developments
- 6.12 TechNanoIndia
- 6.12.1 TechNanoIndia Company Information
- 6.12.2 TechNanoIndia Business Overview
- 6.12.3 TechNanoIndia Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 TechNanoIndia Nanomedicine Manufacturing Services Product Portfolio
- 6.12.5 TechNanoIndia Recent Developments
- 6.13 Encapsula NanoSciences
- 6.13.1 Encapsula NanoSciences Company Information
- 6.13.2 Encapsula NanoSciences Business Overview
- 6.13.3 Encapsula NanoSciences Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Encapsula NanoSciences Nanomedicine Manufacturing Services Product Portfolio
- 6.13.5 Encapsula NanoSciences Recent Developments
- 6.14 STA Pharmaceutical Co. Ltd.
- 6.14.1 STA Pharmaceutical Co. Ltd. Company Information
- 6.14.2 STA Pharmaceutical Co. Ltd. Business Overview
- 6.14.3 STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Product Portfolio
- 6.14.5 STA Pharmaceutical Co. Ltd. Recent Developments
7 North America
- 7.1 North America Nanomedicine Manufacturing Services Market Size (2021-2032)
- 7.2 North America Nanomedicine Manufacturing Services Market Size by Type
- 7.2.1 North America Nanomedicine Manufacturing Services Market Size by Type (2021-2026)
- 7.2.2 North America Nanomedicine Manufacturing Services Market Size by Type (2027-2032)
- 7.2.3 North America Nanomedicine Manufacturing Services Market Share by Type (2021-2032)
- 7.3 North America Nanomedicine Manufacturing Services Market Size by Application
- 7.3.1 North America Nanomedicine Manufacturing Services Market Size by Application (2021-2026)
- 7.3.2 North America Nanomedicine Manufacturing Services Market Size by Application (2027-2032)
- 7.3.3 North America Nanomedicine Manufacturing Services Market Share by Application (2021-2032)
- 7.4 North America Nanomedicine Manufacturing Services Market Size by Country
- 7.4.1 North America Nanomedicine Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
- 7.4.3 North America Nanomedicine Manufacturing Services Market Size by Country (2027-2032)
- 7.4.4 North America Nanomedicine Manufacturing Services Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Nanomedicine Manufacturing Services Market Size (2021-2032)
- 8.2 Europe Nanomedicine Manufacturing Services Market Size by Type
- 8.2.1 Europe Nanomedicine Manufacturing Services Market Size by Type (2021-2026)
- 8.2.2 Europe Nanomedicine Manufacturing Services Market Size by Type (2027-2032)
- 8.2.3 Europe Nanomedicine Manufacturing Services Market Share by Type (2021-2032)
- 8.3 Europe Nanomedicine Manufacturing Services Market Size by Application
- 8.3.1 Europe Nanomedicine Manufacturing Services Market Size by Application (2021-2026)
- 8.3.2 Europe Nanomedicine Manufacturing Services Market Size by Application (2027-2032)
- 8.3.3 Europe Nanomedicine Manufacturing Services Market Share by Application (2021-2032)
- 8.4 Europe Nanomedicine Manufacturing Services Market Size by Country
- 8.4.1 Europe Nanomedicine Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
- 8.4.3 Europe Nanomedicine Manufacturing Services Market Size by Country (2027-2032)
- 8.4.4 Europe Nanomedicine Manufacturing Services Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Nanomedicine Manufacturing Services Market Size (2021-2032)
- 9.2 China Nanomedicine Manufacturing Services Market Size by Type
- 9.2.1 China Nanomedicine Manufacturing Services Market Size by Type (2021-2026)
- 9.2.2 China Nanomedicine Manufacturing Services Market Size by Type (2027-2032)
- 9.2.3 China Nanomedicine Manufacturing Services Market Share by Type (2021-2032)
- 9.3 China Nanomedicine Manufacturing Services Market Size by Application
- 9.3.1 China Nanomedicine Manufacturing Services Market Size by Application (2021-2026)
- 9.3.2 China Nanomedicine Manufacturing Services Market Size by Application (2027-2032)
- 9.3.3 China Nanomedicine Manufacturing Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Nanomedicine Manufacturing Services Market Size (2021-2032)
- 10.2 Asia Nanomedicine Manufacturing Services Market Size by Type
- 10.2.1 Asia Nanomedicine Manufacturing Services Market Size by Type (2021-2026)
- 10.2.2 Asia Nanomedicine Manufacturing Services Market Size by Type (2027-2032)
- 10.2.3 Asia Nanomedicine Manufacturing Services Market Share by Type (2021-2032)
- 10.3 Asia Nanomedicine Manufacturing Services Market Size by Application
- 10.3.1 Asia Nanomedicine Manufacturing Services Market Size by Application (2021-2026)
- 10.3.2 Asia Nanomedicine Manufacturing Services Market Size by Application (2027-2032)
- 10.3.3 Asia Nanomedicine Manufacturing Services Market Share by Application (2021-2032)
- 10.4 Asia Nanomedicine Manufacturing Services Market Size by Country
- 10.4.1 Asia Nanomedicine Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
- 10.4.3 Asia Nanomedicine Manufacturing Services Market Size by Country (2027-2032)
- 10.4.4 Asia Nanomedicine Manufacturing Services Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Type
- 11.2.1 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Application
- 11.3.1 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Country
- 11.4.1 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Nanomedicine Manufacturing Services Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst